Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REFERENCES<br />
Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and alum<strong>in</strong>um <strong>in</strong>crease<br />
204<br />
<strong>in</strong> the substantia nigra <strong>of</strong> patients with Park<strong>in</strong>son's disease: an X-ray microanalysis. J.<br />
Neurochem. 56, 446–451.<br />
Hirsh E. C., Hunot S., Damier P. and Faucheux B. (1998) Glial cells and <strong>in</strong>flammation <strong>in</strong><br />
Park<strong>in</strong>son’s disease: a role <strong>in</strong> neurodegeneration? Ann. Neurol. 44, S115–S120.<br />
Hirsch E. C., Hunot S., Faucheux B., Agid Y., Mizuno Y., Mochizuki H., Tatton W. G., Tatton N.<br />
and Olanow W. C. (1999) Dopam<strong>in</strong>ergic neurons degenerate by apoptosis <strong>in</strong> Park<strong>in</strong>son’s<br />
disease. Mov. Disord. 14, 383–385.<br />
Hochstrasser H., Bauer P., Walter U., Behnke S., Spiegel J., Csoti I., Zeiler B., Bornemann A.,<br />
Pahnke J., Becker G., Riess O., Berg D. (2004) Ceruloplasm<strong>in</strong> gene variations are associated<br />
with substantia nigra hyperechogenicity <strong>in</strong> Park<strong>in</strong>son’s disease. Neurology 63, 1912–1917.<br />
Hong S. J., Dawson T. M. and Dawson V. L. (2004) Nuclear and mitochondrial conversations <strong>in</strong><br />
cell death: PARP-1 and AIF signal<strong>in</strong>g. Trends Pharmacol. Sci. 25, 259–264.<br />
Hornykiewicz O. and Kish S. J. (1987) Biochemical pathophysiology <strong>of</strong> Park<strong>in</strong>son’s disease. Adv.<br />
Neurol. 45, 19–34.<br />
Hosovski E., Mastelica Z., Sunderic D. and Radulovic D. (1990) Mental abilities <strong>of</strong> workers<br />
exposed to alum<strong>in</strong>um. Med. Lav. 81, 119–123.<br />
Hsuan S. L., Kl<strong>in</strong>tworth H. M. and Xia Z. (2006) Basic fibroblast growth factor protects aga<strong>in</strong>st<br />
rotenone-<strong>in</strong>duced dopam<strong>in</strong>ergic cell death through activation <strong>of</strong> extracellular signal-<br />
regulated k<strong>in</strong>ases 1/2 and phosphatidyl<strong>in</strong>ositol-3 k<strong>in</strong>ase pathways. J. Neurosci. 26, 4481–<br />
4491.<br />
Hughes A. J., Daniel S. E., Kilford L. and Lees A. J. (1992a) Accuracy <strong>of</strong> cl<strong>in</strong>ical diagnosis <strong>of</strong><br />
idiopathic Park<strong>in</strong>son's disease: a cl<strong>in</strong>ico-pathological study <strong>of</strong> 100 cases. J. Neurol.<br />
Neurosurg. Psychiatry. 55, 181–184.